-
Je něco špatně v tomto záznamu ?
Natural antioxidant pterostilbene as an effective antibiofilm agent, particularly for gram-positive cocci
E. Vaňková, M. Paldrychová, P. Kašparová, K. Lokočová, Z. Kodeš, O. Maťátková, I. Kolouchová, J. Masák
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
CZ.2.16/3.1.00/24503
Operational Programme Prague - Competitiveness
NPU I LO1601
National Programme of Sustainability I
18-26463S
Grantová Agentura České Republiky
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- antibakteriální látky farmakologie MeSH
- antioxidancia farmakologie MeSH
- biofilmy účinky léků růst a vývoj MeSH
- Enterococcus faecalis účinky léků MeSH
- gramnegativní bakterie účinky léků MeSH
- grampozitivní bakterie účinky léků MeSH
- grampozitivní koky účinky léků MeSH
- listy rostlin chemie MeSH
- mikrobiální testy citlivosti MeSH
- Pseudomonas aeruginosa účinky léků MeSH
- rostlinné extrakty farmakologie MeSH
- Staphylococcus epidermidis účinky léků MeSH
- stilbeny farmakologie MeSH
- Vitis chemie MeSH
- Publikační typ
- časopisecké články MeSH
Pterostilbene (PTE), a dimethylated analogue of resveratrol, mostly contained in Vitis vinifera leaves or in other plant sources is well-known for its antioxidant activity. Due to its bioavailability, low hydrophilicity and thus ability to penetrate hydrophobic biological membranes it was found to be an antimicrobial agent. These properties of PTE offer the possibility of its use in the treatment of microbial infections. The emergence of antibiotic resistance of microorganisms is often caused by their ability to form biofilm; new substances with antibiofilm activity are therefore sought. The representatives of opportunistic pathogenic gram-positive and gram-negative bacteria as well as fungi were used for the determination of minimum inhibitory concentrations (MIC50 and MIC80), minimum biofilm inhibitory concentrations (MBIC50 and MBIC80) and minimum biofilm eradication concentrations (MBEC50 and MBEC80) of PTE and commonly used antibiotics erythromycin, polymyxin B or antimycotic amphotericin B. Total biofilm biomass was investigated by crystal violet staining, and the results were confirmed using microscopic techniques. The most significant antibiofilm action was proved for gram-positive cocci, e.g., MBEC50 of PTE for all strains of Staphylococcus epidermidis tested was 25 mg/L. By contrast, the antibiotic ERM did not exhibit antibiofilm activity in most cases. The permeabilization of cell membranes of gram-positive cocci biofilm by MBIC50 and MBEC50 of PTE was confirmed by LIVE/DEAD staining using spinning disc confocal microscopy. PTE significantly influenced the ability of gram-positive cocci to form biofilm and it effectively eradicated pre-formed biofilm in vitro; its potential for the treatment of biofilm-associated infections of Staphylococcus spp. or Enterococcus faecalis is thus apparent.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012439
- 003
- CZ-PrNML
- 005
- 20230601084204.0
- 007
- ta
- 008
- 210420s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11274-020-02876-5 $2 doi
- 035 __
- $a (PubMed)32613312
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Vaňková, E $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic. Eva.Vankova@vscht.cz
- 245 10
- $a Natural antioxidant pterostilbene as an effective antibiofilm agent, particularly for gram-positive cocci / $c E. Vaňková, M. Paldrychová, P. Kašparová, K. Lokočová, Z. Kodeš, O. Maťátková, I. Kolouchová, J. Masák
- 520 9_
- $a Pterostilbene (PTE), a dimethylated analogue of resveratrol, mostly contained in Vitis vinifera leaves or in other plant sources is well-known for its antioxidant activity. Due to its bioavailability, low hydrophilicity and thus ability to penetrate hydrophobic biological membranes it was found to be an antimicrobial agent. These properties of PTE offer the possibility of its use in the treatment of microbial infections. The emergence of antibiotic resistance of microorganisms is often caused by their ability to form biofilm; new substances with antibiofilm activity are therefore sought. The representatives of opportunistic pathogenic gram-positive and gram-negative bacteria as well as fungi were used for the determination of minimum inhibitory concentrations (MIC50 and MIC80), minimum biofilm inhibitory concentrations (MBIC50 and MBIC80) and minimum biofilm eradication concentrations (MBEC50 and MBEC80) of PTE and commonly used antibiotics erythromycin, polymyxin B or antimycotic amphotericin B. Total biofilm biomass was investigated by crystal violet staining, and the results were confirmed using microscopic techniques. The most significant antibiofilm action was proved for gram-positive cocci, e.g., MBEC50 of PTE for all strains of Staphylococcus epidermidis tested was 25 mg/L. By contrast, the antibiotic ERM did not exhibit antibiofilm activity in most cases. The permeabilization of cell membranes of gram-positive cocci biofilm by MBIC50 and MBEC50 of PTE was confirmed by LIVE/DEAD staining using spinning disc confocal microscopy. PTE significantly influenced the ability of gram-positive cocci to form biofilm and it effectively eradicated pre-formed biofilm in vitro; its potential for the treatment of biofilm-associated infections of Staphylococcus spp. or Enterococcus faecalis is thus apparent.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a biofilmy $x účinky léků $x růst a vývoj $7 D018441
- 650 _2
- $a Enterococcus faecalis $x účinky léků $7 D013293
- 650 _2
- $a gramnegativní bakterie $x účinky léků $7 D006090
- 650 _2
- $a grampozitivní bakterie $x účinky léků $7 D006094
- 650 _2
- $a grampozitivní koky $x účinky léků $7 D006095
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a rostlinné extrakty $x farmakologie $7 D010936
- 650 _2
- $a listy rostlin $x chemie $7 D018515
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $7 D011550
- 650 _2
- $a Staphylococcus epidermidis $x účinky léků $7 D013212
- 650 _2
- $a stilbeny $x farmakologie $7 D013267
- 650 _2
- $a Vitis $x chemie $7 D027843
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Paldrychová, M $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Kašparová, P $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Lokočová, K $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Kodeš, Z $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic $7 jo2017970315
- 700 1_
- $a Kolouchová, I $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Masák, J $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 773 0_
- $w MED00006402 $t World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $x 1573-0972 $g Roč. 36, č. 7 (2020), s. 101
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32613312 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20230601084157 $b ABA008
- 999 __
- $a ok $b bmc $g 1650748 $s 1132818
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 36 $c 7 $d 101 $e 20200701 $i 1573-0972 $m World journal of microbiology & biotechnology incorporating the MIRCEN Journal of applied microbiology and biotechnology $n World j. microbiol. biotechnol. $x MED00006402
- GRA __
- $a CZ.2.16/3.1.00/24503 $p Operational Programme Prague - Competitiveness
- GRA __
- $a NPU I LO1601 $p National Programme of Sustainability I
- GRA __
- $a 18-26463S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20210420